Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Béatrice Laupèze"'
Autor:
François Roman, Wivine Burny, Maria Angeles Ceregido, Béatrice Laupèze, Stéphane T Temmerman, Lucile Warter, Margherita Coccia
Publikováno v:
Expert Review of Vaccines, Vol 23, Iss 1, Pp 715-729 (2024)
Introduction The use of novel adjuvants in human vaccines continues to expand as their contribution to preventing disease in challenging populations and caused by complex pathogens is increasingly understood. AS01 is a family of liposome-based vaccin
Externí odkaz:
https://doaj.org/article/81dc6633736e41b888d3b814f3660234
Autor:
Béatrice Laupèze, T. Mark Doherty
Publikováno v:
Expert Review of Vaccines, Vol 22, Iss 1, Pp 256-266 (2023)
Introduction Conventionally, vaccines are thought to induce a specific immune response directed against a target pathogen. Long recognized but poorly understood nonspecific benefits of vaccination, such as reduced susceptibility to unrelated diseases
Externí odkaz:
https://doaj.org/article/04e6a7b3525941279dcdf148f60e35bb
Publikováno v:
npj Vaccines, Vol 6, Iss 1, Pp 1-10 (2021)
Abstract The primary goal of vaccination is the prevention of pathogen-specific infection. The indirect consequences may include maintenance of homeostasis through prevention of infection-induced complications; trained immunity that re-programs innat
Externí odkaz:
https://doaj.org/article/07346b6c4d044d88ad114ce7ad6a5c8b
Autor:
Arnaud M. Didierlaurent, Béatrice Laupèze, Alberta Di Pasquale, Nadia Hergli, Catherine Collignon, Nathalie Garçon
Publikováno v:
Expert Review of Vaccines, Vol 16, Iss 1, Pp 55-63 (2017)
Introduction: Adjuvants are used to improve vaccine immunogenicity and efficacy by enhancing antigen presentation to antigen-specific immune cells with the aim to confer long-term protection against targeted pathogens. Adjuvants have been used in vac
Externí odkaz:
https://doaj.org/article/e4e83bb0a82e4bf49eec7f45bd0bc81a
Autor:
Fernanda Tavares Da Silva, Caroline Hervé, Arnaud Didierlaurent, Béatrice Laupèze, Giuseppe Del Giudice
Publikováno v:
npj Vaccines, Vol 4, Iss 1, Pp 1-11 (2019)
NPJ Vaccines
NPJ Vaccines
Reactogenicity represents the physical manifestation of the inflammatory response to vaccination, and can include injection-site pain, redness, swelling or induration at the injection site, as well as systemic symptoms, such as fever, myalgia, or hea
Vaccine development has traditionally been driven by the need to prevent high numbers of childhood deaths due to infectious disease. With few exceptions, vaccines for adults are the same as vaccines for infants, although it has long been apparent tha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a003a60fabe49c6d25a1633ef51cbcd6
https://doi.org/10.1159/000504485
https://doi.org/10.1159/000504485
Publikováno v:
Vaccine. 37(38)
Adjuvant Systems (AS) are combinations of immune stimulants that enhance the immune response to vaccine antigens. The first vaccine containing an AS (AS04) was licensed in 2005. As of 2018, several vaccines containing AS04, AS03 or AS01 have been lic
Publikováno v:
Interdisciplinary topics in gerontology and geriatrics. 43
Vaccine development has traditionally been driven by the need to prevent high numbers of childhood deaths due to infectious disease. With few exceptions, vaccines for adults are the same as vaccines for infants, although it has long been apparent tha
Autor:
José M. Bayas, Lidia Oostvogels, Béatrice Laupèze, Carine Claeys, Robert B. Couch, Philippe Moris, Mohamed El Idrissi, Caroline Hervé, Covadonga Caso, Concepción Núñez López, Innocent N. Mbawuike
Publikováno v:
Dipòsit Digital de la UB
Universidad de Barcelona
BMC Infectious Diseases
Recercat. Dipósit de la Recerca de Catalunya
instname
Universidad de Barcelona
BMC Infectious Diseases
Recercat. Dipósit de la Recerca de Catalunya
instname
Background The effectiveness of trivalent influenza vaccines may be reduced in older versus younger adults because of age-related immunosenescence. The use of an adjuvant in such a vaccine is one strategy that may combat immunosenescence, potentially
Autor:
Yasmine Sebti, Renée Fauchet, Olivier Fardel, Béatrice Laupèze, Alain Beauplet, Gaëlle Le Friec, Valérie Guilloux, Céline Pangault, Laurence Amiot
Publikováno v:
Human immunology. 64(8)
The role of the nonclassical human leukocyte antigen (HLA) class Ib molecule HLA-G in immune tolerance was first reported at maternofetal interface. This immunomodulating role could be exerted more generally in tumoral or post-transplantation situati